Table 3.
Summary of cases that developed radiation-induced liver disease after the first and second SBRT.
| Case | Timing | Pre-SBRT C–P class (score) | Dose fractionation | Normal liver volume | Cumulative MLD | Hepatotoxicity | Post-SBRT C–P class (score) |
|---|---|---|---|---|---|---|---|
| 67/M | First | A (5) | 60 Gy/3fx | 1274 cm3 | 5.7 Gy | Gr 3 (AST/ALT)* | A (5) |
| 70/M | Second | B (7) | 45 Gy/3fx | 1139 cm3 | 12.5 Gy | Gr 3 (Bilirubin) | C (12)* |
| 58/M | Second | B (7) | 45 Gy/3fx | 794 cm3 | 19.3 Gy | Gr 2 (Bilirubin)* | B (9)* |
Abbreviations: SBRT, stereotactic body radiation therapy; C–P, Child–Pugh; MLD, mean liver dose; Gr, grade; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
*Toxicities that meet the pre-defined criteria of radiation-induced liver disease.